Pharmaceutical firm Wockhardt 's third consolidated net profit increased 14 percent year-on-year to Rs 347 crore led by strong operational income and other income.
Consolidated total income rose 11.8 percent to Rs 1,382 crore during October-December quarter from Rs 1,236.4 crore in the year-ago period.
Operating profit (EBITDA) surged 92.4 percent on yearly basis to Rs 463 crore and operating profit margin spiked a whopping 1400 basis points to 33.5 percent in the quarter ended December 2014.
Other income jumped 4.5 times year-on-year to Rs 28.5 crore while finance cost declined to Rs 12 crore from Rs 30.5 crore during the same period.
Wockhardt has posted a forex loss of Rs 34.5 crore for the quarter as against gain of Rs 79.94 crore in the year-ago period.
Total expenses dropped significantly to Rs 956.13 crore from Rs 1030 crore and tax expenses climbed to Rs 57.63 crore from Rs 11.55 crore during the same period.
The board of directors of the drug maker has re-appointed Habil Khorakiwala as chairman for another five years.
At 13:33 hours IST, the stock was quoting at Rs 1,241.00, up Rs 58.55, or 4.95 percent on the BSE.